Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

Molecular Cancer Therapeutics

Volumn 7, Issue 2, 2008, Pages 286-296

  Li, Min ^a   Bharadwaj, Uddalak ^a   Zhang, Rongxin ^a   Zhang, Sheng ^a   Mu, Hong ^a   Fisher, William E ^a   Brunicardi, F Charles ^a   Chen, Changyi ^a   Yao, Qizhi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; HUMAN MESOTHELIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CANCER CELL; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT; VIRUS LIKE AGENT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOTHERAPY, ACTIVE; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, NUDE; PANCREATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; VIRION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 39749173738     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-0483     Document Type: Article

References (46)